Clinical Profile and Outcomes of Patients Deemed Ineligible for Transcatheter Tricuspid Valve Intervention
Canadian Journal of Cardiology · 2026-09 · 42 (9) · 2076-2084
DOI: 10.1016/j.cjca.2026.05.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Cardiology, 2026-09. Verfasst von Chloe Kharsa und 16 weiteren Autor:innen. Beteiligte Einrichtung: Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. Electronic address: https://x.com/KharsaChloe. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Cardiac Catheterization, Tricuspid Valve, Heart Valve Prosthesis Implantation. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Transcatheter tricuspid valve intervention (TTVI) has expanded therapeutic options for tricuspid regurgitation (TR); however, a substantial proportion of patients remain ineligible because of anatomical and clinical constraints. We sought to characterize patients screened out from TTVI and evaluate their clinical outcomes. METHODS: In this single-centre retrospective cohort study (January 2021 to May 2025), we included consecutive patients with symptomatic severe TR referred for TTVI evaluation who were deemed ineligible by a multidisciplinary heart team. Patients were identified through institutional logs and clinical trial screening databases. Baseline clinical, echocardiographic, and hemodynamic data were collected. Outcomes included 1-year all-cause mortality, heart failure hospitalization (HFH), and their composite. RESULTS: Among 205 patients evaluated, 83 (40.5%) were deemed ineligible. The mean age was 72.2 years, with a high burden of comorbidities. Severe or torrential TR was present in 84.4% of patients. The most frequent reasons for exclusion were unfavourable anatomy, including significant tricuspid annular dilation (69.5%) and a coaptation gap ≥ 7-10 mm (59.8%). Patients who died within 1 year had higher right-sided filling pressures on invasive hemodynamic assessment. At 1 year, all-cause mortality was 20.5%, HFH occurred in 31.3%, and the composite end point in 51.8%. Kaplan-Meier estimates showed survival of 77.5% and freedom from HFH of 58.3% at 12 months. CONCLUSIONS: Patients deemed ineligible for TTVI represent a high-risk cohort with substantial morbidity and mortality at 1 year. These findings underscore the importance of earlier referral, optimized screening strategies, and continued device innovation to expand treatment eligibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. Electronic address: https://x.com/KharsaChloe.
- Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
- Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. Electronic address: https://x.com/KrityaMangesh.
- Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. Electronic address: https://x.com/NadeenFaza.
- Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. Electronic address: https://x.com/SLittleMD.
- Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. Electronic address: https://x.com/mdatkins.
Zitieren
APA
Kharsa, C., Sella, G., Kritya, M., Hatab, T., Samimi, S., Bhimaraj, A., Guha, A., Gorthi, J. R., Fernando, R. D. V., Faza, N. N., Little, S. H., Atkins, M. D., Zoghbi, W., Aoun, J., Kleiman, N. S., Reardon, M. J., & Goel, S. S. (2026). Clinical Profile and Outcomes of Patients Deemed Ineligible for Transcatheter Tricuspid Valve Intervention. Canadian Journal of Cardiology, 42(9), 2076-2084. https://doi.org/10.1016/j.cjca.2026.05.004
Vancouver
Kharsa C, Sella G, Kritya M, Hatab T, Samimi S, Bhimaraj A, et al. Clinical Profile and Outcomes of Patients Deemed Ineligible for Transcatheter Tricuspid Valve Intervention. Canadian Journal of Cardiology. 2026;42(9):2076-2084. doi:10.1016/j.cjca.2026.05.004
BibTeX
@article{Kharsa2026,
author = {Kharsa, Chloe and Sella, Gal and Kritya, Mangesh and Hatab, Taha and Samimi, Sahar and Bhimaraj, Arvin and Guha, Ashrith and Gorthi, Janardhana R and Fernando, Ramirez Del Val and Faza, Nadeen N and Little, Stephen H and Atkins, Marvin D and Zoghbi, William and Aoun, Joe and Kleiman, Neal S and Reardon, Michael J and Goel, Sachin S},
title = {Clinical Profile and Outcomes of Patients Deemed Ineligible for Transcatheter Tricuspid Valve Intervention},
journal = {Canadian Journal of Cardiology},
year = {2026},
volume = {42},
number = {9},
pages = {2076--2084},
doi = {10.1016/j.cjca.2026.05.004}
}
EUVIMED